[A short-term test using DDAVP for determination of the renal concentration capacity (author's transl)].
A short-term test to determine renal concentrating ability without any water deprivation has been described. It consists of osmolatity determinations in three onehour urine portions from spontaneous voidings following an intranasal application of 7 microng of the synthetic analogue of vasopressin-DDAVP per 0,5 m2 body surface. The values of maximal urine osmalatity over 900 mosm/Kg H2O following DDAVP are considered normal whereas values under 600 mosm are consistent with impaired renal function. If, however, the maximal urine osmolality is in the so called "uncertain range" i.e. from 600 to 900 mosm, it is advisable to perform in the same patients also the classical concentration test based on a prolonged dehydration (26 h).
D000281:Administration, Intranasal; D000293:Adolescent; D002648:Child; D003894:Deamino Arginine Vasopressin; D005260:Female; D006801:Humans; D007671:Kidney Concentrating Ability; D008297:Male; D008722:Methods; D013997:Time Factors; D014667:Vasopressins / Q000031:analogs & derivatives*
D014667:Vasopressins; D003894:Deamino Arginine Vasopressin
Erfahrungen mit einem DDAVP -Schnelltest zur Bestimmung der Konzentrationsfähigkeit der Niere